QSAR Model of Indeno[1,2-<i>b</i>]indole Derivatives and Identification of <i>N</i>-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-<i>b</i>]furan-3-carboxamide as a Potent CK2 Inhibitor

Casein kinase II (CK2) is an intensively studied enzyme, involved in different diseases, cancer in particular. Different scaffolds were used to develop inhibitors of this enzyme. Here, we report on the synthesis and biological evaluation of twenty phenolic, ketonic, and <i>para</i>-quino...

Full description

Bibliographic Details
Main Authors: Samer Haidar, Christelle Marminon, Dagmar Aichele, Abdelhamid Nacereddine, Wael Zeinyeh, Abdeslem Bouzina, Malika Berredjem, Laurent Ettouati, Zouhair Bouaziz, Marc Le Borgne, Joachim Jose
Format: Article
Language:English
Published: MDPI AG 2019-12-01
Series:Molecules
Subjects:
ck2
Online Access:https://www.mdpi.com/1420-3049/25/1/97
id doaj-cead735122584236b050184220a83eb4
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Samer Haidar
Christelle Marminon
Dagmar Aichele
Abdelhamid Nacereddine
Wael Zeinyeh
Abdeslem Bouzina
Malika Berredjem
Laurent Ettouati
Zouhair Bouaziz
Marc Le Borgne
Joachim Jose
spellingShingle Samer Haidar
Christelle Marminon
Dagmar Aichele
Abdelhamid Nacereddine
Wael Zeinyeh
Abdeslem Bouzina
Malika Berredjem
Laurent Ettouati
Zouhair Bouaziz
Marc Le Borgne
Joachim Jose
QSAR Model of Indeno[1,2-<i>b</i>]indole Derivatives and Identification of <i>N</i>-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-<i>b</i>]furan-3-carboxamide as a Potent CK2 Inhibitor
Molecules
qsar
cancer
ck2
indeno[1,2-<i>b</i>]indole
naphtho[2,3-<i>b</i>]furan-4,9-dione
author_facet Samer Haidar
Christelle Marminon
Dagmar Aichele
Abdelhamid Nacereddine
Wael Zeinyeh
Abdeslem Bouzina
Malika Berredjem
Laurent Ettouati
Zouhair Bouaziz
Marc Le Borgne
Joachim Jose
author_sort Samer Haidar
title QSAR Model of Indeno[1,2-<i>b</i>]indole Derivatives and Identification of <i>N</i>-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-<i>b</i>]furan-3-carboxamide as a Potent CK2 Inhibitor
title_short QSAR Model of Indeno[1,2-<i>b</i>]indole Derivatives and Identification of <i>N</i>-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-<i>b</i>]furan-3-carboxamide as a Potent CK2 Inhibitor
title_full QSAR Model of Indeno[1,2-<i>b</i>]indole Derivatives and Identification of <i>N</i>-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-<i>b</i>]furan-3-carboxamide as a Potent CK2 Inhibitor
title_fullStr QSAR Model of Indeno[1,2-<i>b</i>]indole Derivatives and Identification of <i>N</i>-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-<i>b</i>]furan-3-carboxamide as a Potent CK2 Inhibitor
title_full_unstemmed QSAR Model of Indeno[1,2-<i>b</i>]indole Derivatives and Identification of <i>N</i>-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-<i>b</i>]furan-3-carboxamide as a Potent CK2 Inhibitor
title_sort qsar model of indeno[1,2-<i>b</i>]indole derivatives and identification of <i>n</i>-isopentyl-2-methyl-4,9-dioxo-4,9-dihydronaphtho[2,3-<i>b</i>]furan-3-carboxamide as a potent ck2 inhibitor
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2019-12-01
description Casein kinase II (CK2) is an intensively studied enzyme, involved in different diseases, cancer in particular. Different scaffolds were used to develop inhibitors of this enzyme. Here, we report on the synthesis and biological evaluation of twenty phenolic, ketonic, and <i>para</i>-quinonic indeno[1,2-<i>b</i>]indole derivatives as CK2 inhibitors. The most active compounds were 5-isopropyl-1-methyl-5,6,7,8-tetrahydroindeno[1,2-<i>b</i>]indole-9,10-dione <b>4h</b> and 1,3-dibromo-5-isopropyl-5,6,7,8-tetrahydroindeno[1,2-<i>b</i>]indole-9,10-dione <b>4w</b> with identical IC<sub>50</sub> values of 0.11 &#181;M. Furthermore, the development of a QSAR model based on the structure of indeno[1,2-<i>b</i>]indoles was performed. This model was used to predict the activity of 25 compounds with naphtho[2,3-<i>b</i>]furan-4,9-dione derivatives, which were previously predicted as CK2 inhibitors via a molecular modeling approach. The activities of four naphtho[2,3-<i>b</i>]furan-4,9-dione derivatives were determined in vitro and one of them (<i>N</i>-isopentyl-2-methyl-4,9-dioxo-4,9-dihydronaphtho[2,3-<i>b</i>]furan-3-carboxamide) turned out to inhibit CK2 with an IC<sub>50</sub> value of 2.33 &#181;M. All four candidates were able to reduce the cell viability by more than 60% after 24 h of incubation using 10 &#181;M.
topic qsar
cancer
ck2
indeno[1,2-<i>b</i>]indole
naphtho[2,3-<i>b</i>]furan-4,9-dione
url https://www.mdpi.com/1420-3049/25/1/97
work_keys_str_mv AT samerhaidar qsarmodelofindeno12ibiindolederivativesandidentificationofiniisopentyl2methyl49dioxo49dihydronaphtho23ibifuran3carboxamideasapotentck2inhibitor
AT christellemarminon qsarmodelofindeno12ibiindolederivativesandidentificationofiniisopentyl2methyl49dioxo49dihydronaphtho23ibifuran3carboxamideasapotentck2inhibitor
AT dagmaraichele qsarmodelofindeno12ibiindolederivativesandidentificationofiniisopentyl2methyl49dioxo49dihydronaphtho23ibifuran3carboxamideasapotentck2inhibitor
AT abdelhamidnacereddine qsarmodelofindeno12ibiindolederivativesandidentificationofiniisopentyl2methyl49dioxo49dihydronaphtho23ibifuran3carboxamideasapotentck2inhibitor
AT waelzeinyeh qsarmodelofindeno12ibiindolederivativesandidentificationofiniisopentyl2methyl49dioxo49dihydronaphtho23ibifuran3carboxamideasapotentck2inhibitor
AT abdeslembouzina qsarmodelofindeno12ibiindolederivativesandidentificationofiniisopentyl2methyl49dioxo49dihydronaphtho23ibifuran3carboxamideasapotentck2inhibitor
AT malikaberredjem qsarmodelofindeno12ibiindolederivativesandidentificationofiniisopentyl2methyl49dioxo49dihydronaphtho23ibifuran3carboxamideasapotentck2inhibitor
AT laurentettouati qsarmodelofindeno12ibiindolederivativesandidentificationofiniisopentyl2methyl49dioxo49dihydronaphtho23ibifuran3carboxamideasapotentck2inhibitor
AT zouhairbouaziz qsarmodelofindeno12ibiindolederivativesandidentificationofiniisopentyl2methyl49dioxo49dihydronaphtho23ibifuran3carboxamideasapotentck2inhibitor
AT marcleborgne qsarmodelofindeno12ibiindolederivativesandidentificationofiniisopentyl2methyl49dioxo49dihydronaphtho23ibifuran3carboxamideasapotentck2inhibitor
AT joachimjose qsarmodelofindeno12ibiindolederivativesandidentificationofiniisopentyl2methyl49dioxo49dihydronaphtho23ibifuran3carboxamideasapotentck2inhibitor
_version_ 1724875603791839232
spelling doaj-cead735122584236b050184220a83eb42020-11-25T02:19:36ZengMDPI AGMolecules1420-30492019-12-012519710.3390/molecules25010097molecules25010097QSAR Model of Indeno[1,2-<i>b</i>]indole Derivatives and Identification of <i>N</i>-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-<i>b</i>]furan-3-carboxamide as a Potent CK2 InhibitorSamer Haidar0Christelle Marminon1Dagmar Aichele2Abdelhamid Nacereddine3Wael Zeinyeh4Abdeslem Bouzina5Malika Berredjem6Laurent Ettouati7Zouhair Bouaziz8Marc Le Borgne9Joachim Jose10Institut für Pharmazeutische und Medizinische Chemie, PharmaCampus, Westfälische Wilhelms-Universität Münster, Corrensstr. 48, 48149 Münster, GermanyFaculté de Pharmacie—ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453—INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, 8 Avenue Rockefeller, F-69373 Lyon CEDEX 8, FranceInstitut für Pharmazeutische und Medizinische Chemie, PharmaCampus, Westfälische Wilhelms-Universität Münster, Corrensstr. 48, 48149 Münster, GermanyFaculté de Pharmacie—ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453—INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, 8 Avenue Rockefeller, F-69373 Lyon CEDEX 8, FranceFaculté de Pharmacie—ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453—INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, 8 Avenue Rockefeller, F-69373 Lyon CEDEX 8, FranceFaculté de Pharmacie—ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453—INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, 8 Avenue Rockefeller, F-69373 Lyon CEDEX 8, FranceLaboratory of Applied Organic Chemistry, Synthesis of Biomolecules and Molecular Modelling Group, Badji-Mokhtar—Annaba University, Box 12, Annaba 23000, AlgeriaFaculté de Pharmacie—ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453—INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, 8 Avenue Rockefeller, F-69373 Lyon CEDEX 8, FranceFaculté de Pharmacie—ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453—INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, 8 Avenue Rockefeller, F-69373 Lyon CEDEX 8, FranceFaculté de Pharmacie—ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453—INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, 8 Avenue Rockefeller, F-69373 Lyon CEDEX 8, FranceInstitut für Pharmazeutische und Medizinische Chemie, PharmaCampus, Westfälische Wilhelms-Universität Münster, Corrensstr. 48, 48149 Münster, GermanyCasein kinase II (CK2) is an intensively studied enzyme, involved in different diseases, cancer in particular. Different scaffolds were used to develop inhibitors of this enzyme. Here, we report on the synthesis and biological evaluation of twenty phenolic, ketonic, and <i>para</i>-quinonic indeno[1,2-<i>b</i>]indole derivatives as CK2 inhibitors. The most active compounds were 5-isopropyl-1-methyl-5,6,7,8-tetrahydroindeno[1,2-<i>b</i>]indole-9,10-dione <b>4h</b> and 1,3-dibromo-5-isopropyl-5,6,7,8-tetrahydroindeno[1,2-<i>b</i>]indole-9,10-dione <b>4w</b> with identical IC<sub>50</sub> values of 0.11 &#181;M. Furthermore, the development of a QSAR model based on the structure of indeno[1,2-<i>b</i>]indoles was performed. This model was used to predict the activity of 25 compounds with naphtho[2,3-<i>b</i>]furan-4,9-dione derivatives, which were previously predicted as CK2 inhibitors via a molecular modeling approach. The activities of four naphtho[2,3-<i>b</i>]furan-4,9-dione derivatives were determined in vitro and one of them (<i>N</i>-isopentyl-2-methyl-4,9-dioxo-4,9-dihydronaphtho[2,3-<i>b</i>]furan-3-carboxamide) turned out to inhibit CK2 with an IC<sub>50</sub> value of 2.33 &#181;M. All four candidates were able to reduce the cell viability by more than 60% after 24 h of incubation using 10 &#181;M.https://www.mdpi.com/1420-3049/25/1/97qsarcancerck2indeno[1,2-<i>b</i>]indolenaphtho[2,3-<i>b</i>]furan-4,9-dione